Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.

Janjan, N A; Abbruzzese, J; Pazdur, R; Khoo, V S; Cleary, K; Dubrow, R; Ajani, J; Rich, T A; Goswitz, M S; Evetts, P A; Allen, P K; Lynch, P M; Skibber, J M

Janjan, N A; Abbruzzese, J; Pazdur, R; Khoo, V S; Cleary, K; Dubrow, R; Ajani, J; Rich, T A; Goswitz, M S; Evetts, P A; Allen, P K; Lynch, P M; Skibber, J M.

Affiliation

Janjan NA; Department of Radiation Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.

Radiother Oncol ; 51(2): 153-60, 1999 May.

Article in En | MEDLINE | ID: mdl-10435807

Subject(s)

Antimetabolites, Antineoplastic/therapeutic use; Fluorouracil/therapeutic use; Rectal Neoplasms/drug therapy; Rectal Neoplasms/radiotherapy; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Preoperative Care; Prognosis; Radiotherapy Dosage; Rectal Neoplasms/mortality; Rectal Neoplasms/pathology; Survival Analysis

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Rectal Neoplasms / Fluorouracil / Antimetabolites, Antineoplastic Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 1999 Type: Article

Search on Google

XML

PubMed Links